Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 2, Pages 748-753Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI123623
Keywords
-
Categories
Funding
- National Institutes of Health [R56-AI096882, R01-AI096882, T32-HD043003, K12-HD043372, R01-AI070101, R01-AI124680, R01-AI126890, R01-AI136533, R01-AI105035, U01-AI131314]
- Ohio State University Clinical and Translational Science Awards Program [UL1TR002733]
- Office of Research Infrastructure Programs [P51OD011132]
- Abigail Wexner Research Institute at Nationwide Children's Hospital
Ask authors/readers for more resources
Chronic hepatitis C virus (HCV) infection is characterized by persistent high-level viremia and defective cellular immunity, including a lack of functional HCV-specific CD4(+) T cells. We previously described an exceptional period of viral control that occurs in some chronically infected women after childbirth. Here, we investigated whether reduced HCV replication after pregnancy is associated with recovery of CD4(+ )T cell immunity. Class II tetramer analysis revealed significantly greater frequencies of circulating HCV-specific CD4(+) T cells at 3 months postpartum in women with concurrent declines in viremia compared with those with stable viremia. These HCV-specific CD4(+)T cells had an effector-memory phenotype. Inhibitory coreceptor expression on these cells corresponded to the degree of viral control. Circulating CD4(+) T cells produced IL-2 and IFN-gamma after HCV antigen stimulation, demonstrating Th1 functionality. These data provide direct evidence that the profound loss of HCV-specific CD4(+) T cell help that results in chronic infection is reversible following pregnancy, and this recovery of CD4(+) T cells is associated with at least transient control of persistent viral replication.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available